The event is an official activity within the framework of the State visit of the President of France to Vietnam, at the invitation of President Luong Cuong. The visit is of special significance as the two countries have just upgraded their relations to a Comprehensive Strategic Partnership since October 2024, during General Secretary To Lam's official visit to France.
The announcement of the cooperation agreement between VNVC and Sanofi on the transfer of vaccine production technology is a clear demonstration of the trust and efforts of both sides to reach new heights in essential areas of the globalization era such as healthcare and healthcare.
Speaking at the press conference after the document handover, President Luong Cuong said that Vietnam and France have recognized cooperation in the fields of tradition, science and technology, health, education and training and many development aspects in the context of the new relationship.
The two sides agreed to promote cooperation in areas of strength such as aerospace, nuclear energy, artificial intelligence, digital transformation, pharmaceuticals and promoting technology transfer.
Accordingly, the agreement on transferring vaccine production technology between Van vaccine Company VNVC and Sanofi - a leading French pharmaceutical group - is a concrete demonstration of the realization of strategic cooperation between the two countries, laying the foundation for the development of bilateral relations in the health sector not only in trade and human resource training, but also expanding and enhancing cooperation in the fields of scientific research, technology transfer, and high-tech vaccine production.
The cooperation is expected to bring great and long-term benefits to the people of the two countries in the fields of health care and health care while creating a solid driving force and legal basis for bilateral activities in health, pharmaceuticals and vaccines in the coming time.
This is also an important step for the Vietnamese health sector to expand international cooperation in high-level science and technology, gradually proactively strengthening national health security, improving the capacity to respond to future epidemic challenges, creating a solid foundation for remarkable development in the field of biomedical medicine, bringing practical benefits to the people.
According to the cooperation agreement, VNVC and Sanofi will gradually deploy technology transfer to produce a number of important Sanofi vaccines in large quantities in Vietnam. In addition, Sanofi also accompanies VNVC in training human resources and managing quality in vaccine research and production.
Speaking about the meaning of this cooperation, Mr. Ngo Chi Dung, General Director and Chairman of the Board of Directors of VNVC Vaccine Company, said that in the context of the Party and the State, it is creating the most favorable conditions for the development of the private economy, especially in the field of international cooperation on science and technology, the cooperation in technology transfer with Sanofi - the world's leading vaccine producer, which helps Vietnam in particular, the Vietnam vaccine in particular In general, quickly improving the capacity to produce high quality "Made in Vietnam" vaccines similar to the world.
Technology transfer allows Vietnam to quickly access leading modern technologies, optimize research and development activities, promptly serve domestic needs and firmly ensure national health security.
The cooperation agreement with Sanofi, a pharmaceutical group with more than 100 years of experience and global influence, is an opportunity for Vietnam to access the world's leading vaccine production technology, thereby being able to proactively produce hundreds of millions of high-quality vaccine doses each year to serve domestic demand, even for export.
Proactively domestically manufacturing will help provide a full source of high-quality vaccines and reduce vaccine costs for people. This is very meaningful in the vaccine coverage strategy, protecting the health of all people, thereby reducing the burden of disease, reducing medical examination and treatment costs, and improving the quality of life, Mr. Ngo Chi Dung hopes.
In a strategic vision of contributing to the goal of national vaccine autonomy, VNVC will build a modern VNVC Vaccin and Food Factory, with a scale of up to 26,000 m2 in Long An province. With an initial investment of VND 2,000 billion, the VNVC vaccine factory is designed to meet the highest standards of the most modern Good Medicine Production Practice (GMP) of the World Health Organization (WHO), the European Union (EU), and the US Food and Drug Administration (FDA).
Currently, Sanofi provides tens of millions of doses of high-quality vaccines, serving the need for vaccination services in Vietnam such as vaccines 6 in 1 Hexaxim, 4 in 1 Tetraxim, 3 in 1 against pharyngitis - whooping cough - Adacel - Tetanus, rabies Verorab, penicelliartritis caused by Menactra spondylitis, A Avaxim hepatitis, flu quadriplegia Vaxigrip Tetra, welding typhim VI. Most of these vaccines are provided and safely vaccinated at the system of more than 220 VNVC vaccination centers nationwide with preferential price policies.
It is expected that when these vaccines are produced at the VNVC factory, Vietnam will have abundant supply and reduced costs, bringing opportunities for full vaccination, protecting the health of many children and adults.
